
Article content
Researchers are testing whether a London-made substance used to treat respiratory distress in preemie babies can help treat lung complications triggered by COVID-19.
Scientists at Lawson Health Research Institute, the medical research arm of London’s hospitals, are studying whether London-made bovine lipid extract surfactant suspension (BLES) can improve the outcomes of critically ill COVID-19 patients.
“BLES has been studied in pediatric and adult populations with acute respiratory distress syndrome, and we have found that it improves outcomes in patients with direct lung injury,” St. Joseph’s Health Care London respirologist Jim Lewis said in a release.
“We have proven this treatment effective in the past, and COVID-19 seems to be another prototypic case that we think will respond well.”
Lungs are made up of alveoli, tiny sacs that connect to the blood vessels. The alveoli are where oxygen enters the bloodstream and waste-product carbon dioxide exits.
https://news.google.com/__i/rss/rd/articles/CBMiemh0dHBzOi8vbGZwcmVzcy5jb20vbmV3cy9sb2NhbC1uZXdzL2NvdmlkLTE5LWNhbi1sb25kb24tbWFkZS1wcmVlbWllLXRyZWF0bWVudC1oZWxwLXZpcnVzLXBhdGllbnRzLWxhd3Nvbi10ZWFtLXRvLWZpbmQtb3V00gGoAWh0dHBzOi8vbGZwcmVzcy5jb20vbmV3cy9sb2NhbC1uZXdzL2NvdmlkLTE5LWNhbi1sb25kb24tbWFkZS1wcmVlbWllLXRyZWF0bWVudC1oZWxwLXZpcnVzLXBhdGllbnRzLWxhd3Nvbi10ZWFtLXRvLWZpbmQtb3V0L3djbS83ZThiNGRhZC1mOTBiLTQyOWMtOWQ5Zi02NDU1YTEzYWYwYmYvYW1wLw?oc=5
2020-07-07 19:20:03Z
CBMiemh0dHBzOi8vbGZwcmVzcy5jb20vbmV3cy9sb2NhbC1uZXdzL2NvdmlkLTE5LWNhbi1sb25kb24tbWFkZS1wcmVlbWllLXRyZWF0bWVudC1oZWxwLXZpcnVzLXBhdGllbnRzLWxhd3Nvbi10ZWFtLXRvLWZpbmQtb3V00gGoAWh0dHBzOi8vbGZwcmVzcy5jb20vbmV3cy9sb2NhbC1uZXdzL2NvdmlkLTE5LWNhbi1sb25kb24tbWFkZS1wcmVlbWllLXRyZWF0bWVudC1oZWxwLXZpcnVzLXBhdGllbnRzLWxhd3Nvbi10ZWFtLXRvLWZpbmQtb3V0L3djbS83ZThiNGRhZC1mOTBiLTQyOWMtOWQ5Zi02NDU1YTEzYWYwYmYvYW1wLw
Tidak ada komentar:
Posting Komentar